People
Senior Associate
Mohammed Basama is a senior associate in the Corporate, Finance and Investments practice group in Dubai. He advises sovereign wealth funds, family offices, private equity funds, and corporations on a range of matters including cross-border mergers and acquisitions, joint ventures, reorganisations, corporate governance, and other complex corporate matters. Prior to joining King & Spalding, Mohammed was seconded to the Emirates Investment Authority.
LL.B., Liverpool University, UK
LL.M., Liverpool University, UK
England and Wales
Arabic
English
December 4, 2025
King & Spalding Advises on Major Energy Assets Acquisition and Landmark Clean Energy and Aluminium Decarbonisation Agreements in Abu Dhabi
October 23, 2025
King & Spalding Wins Three IFLR Middle East Awards at IFLR Middle East Awards 2025
Advised e& (formerly Etisalat) on its entry into a groundbreaking AI joint venture with SK Telecom, Deutsche Telekom, Singtel, and SoftBank Corp
Assisted GFH Partners Ltd with its strategic investment in Manrre REIT (CEIC) Plc, a Dubai-based real estate fund specializing in logistics and industrial assets across the UAE and GCC, with a portfolio valued at AED 500 million.
Represented TVM Capital Healthcare in its USD 35 million investment in Boston Oncology Arabia, a bio-generic drug manufacturer in Saudi Arabia.
See more
May 20, 2025
UAE Implements Sweeping Competition Law Reforms with Mandatory Pre-Merger Notifications
November 19, 2024
Saudi Arabia's New Investment Law Attracts Foreign Investments
December 4, 2025
King & Spalding Advises on Major Energy Assets Acquisition and Landmark Clean Energy and Aluminium Decarbonisation Agreements in Abu Dhabi
October 23, 2025
King & Spalding Wins Three IFLR Middle East Awards at IFLR Middle East Awards 2025
Advised e& (formerly Etisalat) on its entry into a groundbreaking AI joint venture with SK Telecom, Deutsche Telekom, Singtel, and SoftBank Corp
Assisted GFH Partners Ltd with its strategic investment in Manrre REIT (CEIC) Plc, a Dubai-based real estate fund specializing in logistics and industrial assets across the UAE and GCC, with a portfolio valued at AED 500 million.
Represented TVM Capital Healthcare in its USD 35 million investment in Boston Oncology Arabia, a bio-generic drug manufacturer in Saudi Arabia.
See more
May 20, 2025
UAE Implements Sweeping Competition Law Reforms with Mandatory Pre-Merger Notifications
November 19, 2024
Saudi Arabia's New Investment Law Attracts Foreign Investments
December 4, 2025
King & Spalding Advises on Major Energy Assets Acquisition and Landmark Clean Energy and Aluminium Decarbonisation Agreements in Abu Dhabi
October 23, 2025
King & Spalding Wins Three IFLR Middle East Awards at IFLR Middle East Awards 2025
LL.B., Liverpool University, UK
LL.M., Liverpool University, UK
England and Wales
Arabic
English